secwatch.observer — SEC 8-K summary
======================================

Issuer:     InspireMD, Inc. (NSPR)
CIK:        0001433607
Form:       8-K
Filed at:   2022-11-08T23:59:59+00:00
Accession:  0001493152-22-030876
Event type: earnings
Sentiment:  neutral
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

InspireMD Q3 2022 revenue up 33.6% to $1.43M; net loss widens to $4.5M
----------------------------------------------------------------------

- CGuard revenue grew 38.8% YoY to $1,430,836; total revenue $1,431,000 (+33.6%).
- Net loss of $4.5M ($0.58/share) vs $4.1M ($0.53) in Q3 2021; operating expenses up 20.7%.
- Cash and equivalents $21.0M at Sep 30, 2022, down from $34.0M at Dec 31, 2021.
- CE Mark under MDR expires Nov 12; company preparing inventory for potential recertification delay.
- C-Guardian US IDE trial on track with 24 sites; enrollment completion expected by end of Q1 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1433607/000149315222030876/0001493152-22-030876-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1433607/000149315222030876/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-22-030876

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer